TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.

The TGF-beta isoforms, TGF-beta1, -beta2, and -beta3, share greater than 70% sequence identity and are almost structurally identical. TGF-beta2 differs from the others, however, in that it binds the TGF-beta type II receptor (TbetaR-II) with much lower affinity than either TGF-beta1 or -beta3. It has been previously shown that three conserved interfacial residues, Arg25, Val92, Arg94, in TGF-beta1 and -beta3 are responsible for their high-affinity interaction with TbetaR-II. In this study, the role of each of these residues was examined by creating single, double, and triple substitutions resulting in both TGF-beta3 loss-of-function and TGF-beta2 gain-of-function variants. One-dimensional 1H NMR spectra of the variants confirmed a lack of large structural perturbations. Affinities, kinetics, and thermodynamics for TbetaR-II binding were determined by surface plasmon resonance biosensor analysis. Double substitutions revealed that nearly all of the high-affinity binding is contributed by Arg25 and Arg94. Single site substitutions showed that Arg94 makes the greatest contribution. Substitution of Arg25 and Arg94 with alanine verified the requirement of the arginine guanidinium functional groups for the highly specific hydrogen-bonded ion pairs formed between Arg25 and Arg94 of TGF-beta1 and -beta3, and Glu119 and Asp32 of TbetaR-II. Further kinetic and thermodynamic analyses confirmed that Arg25 and Arg94 are primarily responsible for high-affinity binding and also revealed that noninterfacial longer range effects emanating from the TGF-beta structural framework contribute slightly to TbetaR-II binding. Growth inhibition assays showed that binding changes generally correlate directly with changes in function; however, a role Val92 in this cellular context was uncovered.

[1]  W. Stites,et al.  Protein−Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis , 1997 .

[2]  M. O’Connor-McCourt,et al.  Real-time Monitoring of the Interactions of Transforming Growth Factor-β (TGF-β) Isoforms with Latency-associated Protein and the Ectodomains of the TGF-β Type II and III Receptors Reveals Different Kinetic Models and Stoichiometries of Binding* , 2001, The Journal of Biological Chemistry.

[3]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[4]  K. Cutroneo TGF‐β–induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  M. Ferguson,et al.  Transforming growth factor-beta 3 is required for secondary palate fusion. , 1995, Nature genetics.

[6]  J. Massagué TGF-beta signal transduction. , 1998, Annual review of biochemistry.

[7]  K. Miyazono,et al.  Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. , 2007, Oncogene.

[8]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[9]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[10]  C. Hammann,et al.  Comparative thermodynamic analysis of cyclic nucleotide binding to protein kinase A , 2007, Biological chemistry.

[11]  D. Winzor,et al.  Interpretation of the temperature dependence of equilibrium and rate constants , 2006, Journal of molecular recognition : JMR.

[12]  M. Grütter,et al.  The crystal structure of TGF‐β3 and comparison to TGF‐β2: Implications for receptor binding , 1996, Protein science : a publication of the Protein Society.

[13]  R. Hodges,et al.  Real-time monitoring of the interactions of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding. , 2003, Biochemistry.

[14]  J. Massagué,et al.  Betaglycan presents ligand to the TGF beta signaling receptor. , 1993, Cell.

[15]  R. Derynck TGF-beta-receptor-mediated signaling. , 1994, Trends in biochemical sciences.

[16]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[17]  Tudor Arvinte,et al.  Conformation and Self-association of Human Recombinant Transforming Growth Factor-β3 in Aqueous Solutions* , 1999, The Journal of Biological Chemistry.

[18]  A. Hinck,et al.  Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor. , 2006, Journal of molecular biology.

[19]  W. Kwiatkowski,et al.  The BMP7/ActRII extracellular domain complex provides new insights into the cooperative nature of receptor assembly. , 2003, Molecular cell.

[20]  M. Grütter,et al.  An unusual feature revealed by the crystal structure at 2.2 Å resolution of human transforming growth fact or-β2 , 1992, Nature.

[21]  D. Winzor,et al.  Interpretation of the temperature dependence of rate constants in biosensor studies. , 2005, Analytical biochemistry.

[22]  A. Hinck,et al.  Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex. , 2002, Nature structural biology.

[23]  F. López‐Casillas,et al.  Recombinant soluble betaglycan is a potent and isoform-selective transforming growth factor-beta neutralizing agent. , 2001, The Biochemical journal.

[24]  D G Myszka,et al.  The ABRF-MIRG'02 study: assembly state, thermodynamic, and kinetic analysis of an enzyme/inhibitor interaction. , 2003, Journal of biomolecular techniques : JBT.

[25]  T. Jardetzky,et al.  Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.

[26]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[27]  D. Davies,et al.  Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily. , 1992, Science.

[28]  R Wieser,et al.  Mechanism of activation of the TGF-beta receptor. , 1994, Nature.

[29]  A. Hinck,et al.  Sequential resonance assignments of the extracellular ligand binding domain of the human TGF-beta type II receptor. , 2000, Journal of biomolecular NMR.

[30]  A. Hinck,et al.  Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. , 2008, Molecular cell.

[31]  M. O’Connor-McCourt,et al.  Enhancement of the Antagonistic Potency of Transforming Growth Factor-β Receptor Extracellular Domains by Coiled Coil-induced Homo- and Heterodimerization* , 2004, Journal of Biological Chemistry.

[32]  J. Massagué,et al.  TGF beta signals through a heteromeric protein kinase receptor complex. , 1992, Cell.